The Best Science, the Best People

It’s our primary investment.

Why
BioAgilytix

Because the best science
demands the best people.

How
You’ll Benefit

Explore the benefit program
and company perks.

What
You’ll Enable

See how your work will
change patiens lives

Why
BioAgilytix

Because the best science
demands the best people.

How
You’ll Benefit

Explore our benefit program
and company perks.

What
You’ll Enable

See how your work will
change patients’ lives.

Where to begin?

Submit your resume today.

Twitter

BioAgilytix Follow

BioAgilytix is a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development.

BioAgilytix @bioagilytix ·

11h

Health centers are the backbone of our communities, providing care and support for everyone in need. That is why during #NationalHealthCenterWeek, we recognize and applaud health centers for their ongoing efforts to help keep us going strong. #HealthCenterWeek #HealthCenters

Reply on Twitter 1556662275188133891 Retweet on Twitter 1556662275188133891 2 Like on Twitter 1556662275188133891 2 Twitter 1556662275188133891

BioAgilytix @bioagilytix ·

6 Aug

Keep up with the latest industry updates in #bioanalysis with the BioAgilytix #newsletter. Subscribe today >> https://bit.ly/3y1soYJ

Reply on Twitter 1555709241377394688 Retweet on Twitter 1555709241377394688 2 Like on Twitter 1555709241377394688 2 Twitter 1555709241377394688

BioAgilytix @bioagilytix ·

4 Aug

Want to know what is new compared to the current FDA and EMEA guidelines Looking to explore that impact on your organization? Join #BioAgilytix in collaboration with @medicon_valley, on Aug. 16th, 2022 for a discussion on the new ICH m10 guidelines. https://bit.ly/3A3VHMC

Reply on Twitter 1555266834236162053 Retweet on Twitter 1555266834236162053 1 Like on Twitter 1555266834236162053 3 Twitter 1555266834236162053

BioAgilytix @bioagilytix ·

3 Aug

Can advanced modalities be leveraged for extensive use for the purpose of drug quantitation? Listen to @JMcNally_BAL, Amanda L. Hays, PhD & Thomas J. Schneider, PhD share their thoughts on PK assessment for advanced modalities in this on-demand #webinar: https://bit.ly/3bDyZkA

Reply on Twitter 1554896889954422784 Retweet on Twitter 1554896889954422784 1 Like on Twitter 1554896889954422784 1 Twitter 1554896889954422784

BioAgilytix @bioagilytix ·

3 Aug

Christian Braithwaite, Manager II, is among the authors who contributed to a pivotal paper in drug development that demonstrates a different way of measuring the magnitude of #ADA using signal to noise versus titer. Published by @AAPSComms: https://bit.ly/3PT35zE

Reply on Twitter 1554892880283684864 Retweet on Twitter 1554892880283684864 1 Like on Twitter 1554892880283684864 1 Twitter 1554892880283684864

Facebook

877

BioAgilytix

BioAgilytix is a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development.

BioAgilytix

14 hours ago

Health centers are the backbone of our communities, providing care and support for those in need.During #NationalHealthCenterWeek, we applaud health centers for their ongoing efforts to help keep us going strong.#HealthCenterWeek #HealthCenters ... See MoreSee Less

Photo

View on Facebook

BioAgilytix

4 days ago

Keep up with the latest industry updates in #bioanalysis with the BioAgilytix #newsletter. Subscribe today >> bit.ly/3y1soYJ ... See MoreSee Less

Photo

View on Facebook

BioAgilytix

5 days ago

Planning to be in Copenhagen on August 16th? If so, please join #BioAgilytix in collaboration with the Medicon Valley Alliance for breakfast and a discussion on the new ICH M10 guidelines.Explore the new guidelines on the bioanalytical landscape with one of the Members of the Expert Working Group for ICH M10 Marianne Scheel Fjording, MSc, Ph.D., Scientific Officer Executive Director, BioAgilytix.Sign up >> bit.ly/3A3VHMC ... See MoreSee Less

Photo

View on Facebook

BioAgilytix

5 days ago

Christian Braithwaite, Manager II at our Boston lab, is among the authors who contributed to a pivotal paper in drug development that demonstrates a different way of measuring the magnitude of #ada using signal to noise versus titer. Click here to read the full paper that was recently published in the July 2022 volume of the American Association of Pharmaceutical Scientists (AAPS) Journal: bit.ly/3PT35zE #thoughtleadership #ADAAssay #research #science #AAPS #biologyagilityanalytics ... See MoreSee Less

Photo

View on Facebook

BioAgilytix

5 days ago

Can advanced modalities be leveraged for extensive use for the purpose of drug quantitation?Listen to Jim McNally, Ph.D., Amanda L. Hays, Ph.D., and Thomas J. Schneider, Ph.D. share their thoughts on PK assessment for advanced modalities in this on-demand webinar: bit.ly/3bDyZkA#webinar #pkassessment #flowcytometry #BioAgilytix ... See MoreSee Less

Photo

View on Facebook